Deka Bank Deutsche Girozentrale Athenex, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$1.36 - $2.94 $43,384 - $93,786	-31,900 Closed	0 $0
Q4 2020 Mar 12, 2021	BUY	$11.06 - $14.01 $154,840 - $196,140	14,000 Added 78.21%	31,900 $349,000
Q3 2020 Oct 29, 2020	BUY	$10.26 - $14.55 $183,654 - $260,445	17,900 New	17,900 $214,000
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $457,216 - $789,600	-37,600 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$9.44 - $19.8 $138,768 - $291,060	14,700 Added 64.19%	37,600 $691,000
Q1 2019 May 10, 2019	BUY	$11.11 - $13.49 $45,551 - $55,309	4,100 Added 21.81%	22,900 $366,000
Q4 2018 Feb 12, 2019	SELL	$10.24 - $15.49 $41,984 - $63,509	-4,100 Reduced 17.9%	18,800 $241,000
Q3 2018 Nov 09, 2018	SELL	$15.53 - $19.97 $9,318 - $11,982	-600 Reduced 2.55%	22,900 $0
Q1 2018 May 03, 2018	BUY	$13.53 - $17.47 $317,955 - $410,545	23,500 New	23,500 $411,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.